Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Oral Hypoglycemic Agents: Biguanides and Glitazones01:26

Oral Hypoglycemic Agents: Biguanides and Glitazones

451
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
451
Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

80
A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of...
80
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

399
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
399
Oral Hypoglycemic Agents: Glinides01:06

Oral Hypoglycemic Agents: Glinides

414
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
414
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

714
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
714
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

363
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
363

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advances in Parkinson's disease management using umbilical cord-derived mesenchymal stem cells.

Journal of neuroimmunology·2026
Same author

Dental Pulp Mesenchymal Stem Cell-Secretome Gel Reverse Areca Nut Induced Oral Submucous Fibrosis in Mice: A Pilot Study.

Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology·2025
Same author

Silver Nanoparticle-Infused Aloe Polysaccharides/ Polyvinyl Alcohol/Sodium Alginate Nanofiber Sheet for Enhanced Burn Wound Healing.

Current drug delivery·2025
Same author

Disease microenvironment preconditioning: An evolving approach to improve therapeutic efficacy of human mesenchymal stromal cells.

International immunopharmacology·2025
Same author

Novel Combination of Traditional Ayurvedic Herb Piper longum L. and Modern Stem Cell Therapy for the Reversal of Glucocorticoid-Induced Osteoporosis.

Molecular nutrition & food research·2025
Same author

Gallic acid-guar gum and chitosan-based polyelectrolyte complex film exhibited enhanced wound healing in full-thickness excision wound model.

Journal of biomaterials science. Polymer edition·2025

Related Experiment Video

Updated: Nov 21, 2025

An In Ovo Model for Testing Insulin-mimetic Compounds
06:09

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

10.9K

Antidiabetics Interactions with Herbs: A Compressive Review.

Kajal Jirapure1, Vaishali Undale1

  • 1Department of Pharmacology, Dr. D. Y. Patil Institute of Pharmaceutical Sciences and Research, Pimpri, Pune,India.

Current Diabetes Reviews
|January 13, 2021
PubMed
Summary

Many people with diabetes use herbal remedies alongside medications, risking potentially dangerous herb-drug interactions. This review explores these interactions, highlighting the need for greater awareness and research.

Keywords:
Herb-drug interactionantidiabetic drugdiabetesmetforminoral hypoglycemic agents (OHA)sulphonylureas

More Related Videos

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

781
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.5K

Related Experiment Videos

Last Updated: Nov 21, 2025

An In Ovo Model for Testing Insulin-mimetic Compounds
06:09

An In Ovo Model for Testing Insulin-mimetic Compounds

Published on: April 23, 2018

10.9K
Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease
08:15

Author Spotlight: Network Pharmacology and Molecular Docking to Decipher the Action of Jiawei Shengjiang San Against Diabetic Kidney Disease

Published on: May 10, 2024

781
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

2.5K

Area of Science:

  • Pharmacology
  • Integrative Medicine
  • Herbal Medicine

Background:

  • Diabetes mellitus is a chronic condition managed with synthetic drugs, but many patients also use traditional herbal remedies.
  • Herbal products are perceived as safe due to their natural origin, leading to widespread co-consumption with conventional antidiabetic treatments.
  • The concurrent use of herbs and antidiabetic drugs can lead to herb-drug interactions (HDI), which are often overlooked.

Purpose of the Study:

  • To review the mechanisms and prediction methods of herb-drug interactions (HDI) in diabetes management.
  • To summarize existing literature on HDIs involving oral hypoglycemic agents and herbs.
  • To categorize these interactions as beneficial or harmful based on scientific evidence.

Main Methods:

  • Literature review of clinical and experimental studies on herb-drug interactions in diabetes.
  • Analysis of pharmacokinetic and pharmacodynamic mechanisms of HDIs.
  • Categorization of identified HDIs based on reported outcomes.

Main Results:

  • Herb-drug interactions in diabetes can be pharmacokinetic or pharmacodynamic, potentially altering drug efficacy or toxicity.
  • Some herb-drug interactions may be beneficial, while others can be harmful or even fatal.
  • Lack of awareness contributes to the underdiagnosis of these interactions.

Conclusions:

  • Understanding herb-drug interactions is crucial for safe and effective diabetes management.
  • Further research is needed to elucidate mechanisms and predict potential interactions between herbs and antidiabetic drugs.
  • Educating patients and healthcare providers about potential HDIs is essential to prevent adverse events.